Search results
Zinc and respiratory tract infections: Perspectives for COVID‑19. AV Skalny, L Rink, OP Ajsuvakova, M Aschner, VA Gritsenko, ... International journal of molecular medicine 46 (1), 17-26. , 2020.
Michael Aschner, Ph.D., comments on a study that found high concentrations of mercury in ancient bones from Iberia, which researchers believe was caused by exposure to the toxic red pigment made from cinnabar rock. Dr. Aschner is professor of molecular pharmacology, in the Dominick P. Purpura Department of Neuroscience, and of pediatrics, and ...
Oct 7, 2017 · CURRICULUM VITAE – MICHAEL ASCHNER . Part I. ADMINISTRATIVE, RESEARCH, SERVICE, PUBLICATION INFORMATION . CURRENT ACADEMIC TITLE: Harold and Muriel Block Chair in Molecular Pharmacology;
Michael Aschner, Ph.D. Molecular Pharmacology. Phone 718-430-2317. Email michael.aschner @ einsteinmed. edu. h-index. h10-index. h5-index. 46015. Citations. 101. h-index. 1984 … 2024. Research activity per year. Overview. Network. Grants (22) Publications (1156) Similar Profiles (1) Collaborations and top research areas from the last five years.
Michael Aschner's 217 research works with 11,702 citations and 19,944 reads, including: Role of Astrocytes in Parkinson’s Disease Associated with Genetic Mutations and Neurotoxicants
Michael Aschner's 768 research works with 25,514 citations and 4,551 reads, including: Retraction Note: Metallothionein ameliorates airway epithelial apoptosis upon particulate matter...
People also ask
Who is Michael Aschner?
What research topics does Michael Aschner work on?
What grants did Michael Aschner receive?
November 15, 2012 – (BRONX, NY) – Leading neurobiologist Michael Aschner, Ph.D., known for his research on the effect of heavy metals on the brain, will join the faculty of Albert Einstein College of Medicine of Yeshiva University. Dr. Aschner will be named professor of molecular pharmacology and of pediatrics.
